Episode 466: #UromigosLive 2025 - Novel Therapy in mRCC
Brian and Tom tag team moderate this session which covers combination data, VEGF/PD1 bispecifics, microbiome approaches, cellular therapy and enrichment strategies.
--------
53:03
--------
53:03
Episode 465: #UromigosLive 2025 - Adjuvant Therapy in RCC
Tom leads the panel discussion about this evolving space including the RAMPART data and the press release about pembro/belzu.
--------
44:49
--------
44:49
Episode 464: #UromigosLive 2025 - The Evolving Landscape of mHSPC
Brian moderates a panel of Chris Sweeney, Tanya Dorff, Mike Morris, Neeraj Aggarwal and Chuck Ryan as they discus and debate the mHSPC space with many treatment options.
--------
50:04
--------
50:04
Episode 459: #UromigosLive 2025 - Radioligands in Prostate Cancer
Brian leads a discussion of Rana McCay, Chris Sweeney and Michael Morris on the PSMAddition data and the landscape of radioligands in prostate cancer.
--------
37:40
--------
37:40
Episode 458: #UromigosLive 2025 - Mock ODAC
Brian takes the role of the FDA and we conduct a mock ODAC on the CREST and POTOMAC data
Broadcasting the latest developments in GU cancer
Hosted by Brian Rini and Tom Powles
Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
Österreich